Moderna announces vaccine production facility to be built in the Montreal area

·1 min read

MONTREAL — American vaccine maker Moderna has officially announced it will build a facility in the Montreal area to produce mRNA vaccines.

Prime Minister Justin Trudeau, Moderna CEO Stéphane Bancel, and Quebec Premier François Legault gathered today at McGill University's downtown campus to make the announcement.

Moderna's new facility will be the company's first in Canada and will produce mRNA vaccines not only against COVID-19 but also ones that target various respiratory viruses, including influenza and respiratory syncytial virus, or RSV.

Trudeau says the factory will be able to make up to 100 million doses of mRNA vaccines a year, adding that the project will create hundreds of jobs in the region and develop top scientific talent.

Legault says Moderna's project will better prepare Quebec for future pandemics by reinforcing domestic supply chains and vaccine independence.

The Canadian agreement includes both production and vaccine research components, with the facility to be completed by 2024.

Canada's biomanufacturing industry has declined, but what remains is centred in Quebec and the Greater Toronto Area. Both were in the running for the Moderna plant.

This report by The Canadian Press was first published April 29, 2022

The Canadian Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting